A Phase 3 interventional study of Vitamin E and Standard dressing in Surgical Site Infection, sponsored by Hospital General Universitario Elche. Status unknown at 1 site in Spain. Per ClinicalTrials.gov, last updated 2018-02-22.
Sponsored by Hospital General Universitario Elche · Phase 3, Interventional, and Prevention
A prospective, randomized study will be performed. Patients are randomized using a 1:1 allocation into 2 groups: patients receiving a vitamin E-containing dressing (group 1) and a conventional dressing (group 2). The primary outcomes variable will be occurrence of incisional SSI. Follow-up will be 30 days postoperatively.
A prospective, randomized study will be performed. Patients are randomized using a random number table into 1:1 allocation into 2 groups: patients receiving a vitamin E-containing dressing (group 1) and a conventional dressing (group 2). In group 1 the wound will be covered with a Vitamin E embebbed gauze and plastic adhesive tape. In Group 2, , the wound will be covered with standard gauze and plastic adhesive tape.
The primary outcomes variable will be occurrence of incisional SSI, defined by CDC criteria. Follow-up will be 30 days postoperatively.
Exclusion Criteria:
Patients will receive a Vitamin E-containing dressing over the wound
Drug: Vitamin E
Patients will receive a standard dressing over the wound
Drug: Standard dressing
The applied dressing will be embebbed in Vitamin E
Also known as: Exerimental group
The applied dressing is a normal one without adding any product to it.
Also known as: Control group
Incisional surgical site infection
Patients present a wound with the CDC criteria for SSI
Time frame: 30 days postoperatively
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital General Universitario Elche